Vividion Therapeutics, Inc.

📍 San Diego, United States🗓 Founded 2017👥 206 employees💰 Last funded May 2019
Biotechnology Research🌐 vividion.com
Website LinkedIn
Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. The company is advancing a broad, diversified pipeline of multiple, selective small molecule therapeutics for highly sought-after disease-causing target proteins in oncology and immunology. The company’s cutting-edge platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Switzerland
1
Frequently asked questions
Who invested in Vividion Therapeutics, Inc.?
Vividion Therapeutics, Inc. has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Vividion Therapeutics, Inc. last raise funding?
The most recent investment in Vividion Therapeutics, Inc. recorded on gritt.io was in May 2019.
When was Vividion Therapeutics, Inc. founded?
Vividion Therapeutics, Inc. was founded in 2017.
What industry is Vividion Therapeutics, Inc. in?
Vividion Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Vividion Therapeutics, Inc. based?
Vividion Therapeutics, Inc. is headquartered in San Diego, United States.